HUMAN DECIDUA AND FETAL MEMBRANES AS A PARACRINE SYSTEM
人类蜕膜和胎膜作为旁分泌系统
基本信息
- 批准号:3324809
- 负责人:
- 金额:$ 13.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-01-01 至 1995-12-31
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay amnion autoradiography birth chorioallantoic membrane collagenase decidua embryo /fetus membrane endometrium enzyme inhibitors extracellular matrix gene expression hormone receptor hormone regulation /control mechanism human tissue immunocytochemistry in situ hybridization messenger RNA northern blottings paracrine placenta plasminogen activator proteolysis relaxin secretion tissue /cell culture
项目摘要
The potential of the human decidua/fetal membrane system as an accessible
autocrine/paracrine model will be further explored, in order to elucidate
the role of relaxins in the local control of collagenolysis and the rupture
of the fetal membranes at parturition. An added challenge is our finding
that the second human relaxin gene (H1) is expressed in this system.
This will be accomplished by studying the four components of the relaxin
system: gene expression, control of secretion, biological effects and
receptor distribution.
Relaxin H1 and H2 gene expression and the translated products, will be
identified in the endometrium/decidua, fetal membranes and placenta with
specific riboprobes and antibodies throughout the cycle and pregnancy.
The effect on decidual cell relaxin secretion and the mRNA levels for
relaxins by a range of decidual and placental hormones will be studied in
in vitro.
The biological effects of human relaxin H2 on fetal membrane/decidual
production of key collagenolytic enzymes and inhibitors will be sought both
in vitro and in vivo.
Changes in the concentration of relaxin receptors in intrauterine tissues
will be studied through the cycle and gestation by quantitative
autoradiography and the results related to those from the experiments
above.
The combined results will provide insights into significant problems, the
local control of the accommodation of the fetal membranes to the growing
fetus in the last weeks of pregnancy, and the timing of normal spontaneous
membrane rupture. These studies will lead to a greater understanding of
premature rupture of the fetal membranes, a major cause of premature birth
which results in infants with a high incidence of neurodevelopmental
impairment.
人类蜕膜/胎膜系统作为一种可及的
自分泌/旁分泌模型将进一步探讨,以阐明
松弛素在局部控制胶原溶解和破裂中的作用
在分娩时的胎膜。 另一个挑战是我们发现
第二个人松弛素基因(H1)在该系统中表达。
这将通过研究松弛素的四种成分来实现
系统:基因表达、分泌控制、生物学效应和
受体分布
松弛素H1和H2基因表达和翻译产物,将被
在子宫内膜/蜕膜、胎膜和胎盘中发现,
特异性核糖核酸探针和抗体在整个周期和怀孕。
不同浓度地塞米松对蜕膜细胞松弛素分泌及mRNA水平的影响
将研究一系列蜕膜和胎盘激素的松弛作用,
体外
人松弛素H2对胎膜/蜕膜的生物学效应
将寻求关键的胶原蛋白溶解酶和抑制剂的生产,
在体外和体内。
子宫内组织松弛素受体浓度的变化
将通过定量的周期和酝酿进行研究,
放射自显影及与实验相关的结果
以上
综合结果将提供对重大问题的见解,
局部控制胎膜对生长的适应
胎儿在怀孕的最后几周,和正常自发的时间
膜破裂 这些研究将使人们更好地了解
胎膜早破是早产的主要原因
这导致婴儿的神经发育
损伤
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gillian Doreen Bryant-Greenwood其他文献
Gillian Doreen Bryant-Greenwood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gillian Doreen Bryant-Greenwood', 18)}}的其他基金
PROTEINS IN MATERNAL SERUM ASSOCIATED WITH THE PREECLAMPSIA
母体血清中与先兆子痫相关的蛋白质
- 批准号:
7167027 - 财政年份:2005
- 资助金额:
$ 13.78万 - 项目类别:
EQUIPMENT GRANT FOR A FLEXCELL TENSION PLUS SYSTEM
FLEXCELL TENSION PLUS 系统的设备补助金
- 批准号:
6972104 - 财政年份:2004
- 资助金额:
$ 13.78万 - 项目类别:
相似海外基金
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
- 批准号:
10746655 - 财政年份:2023
- 资助金额:
$ 13.78万 - 项目类别:
Collaborative Research: Mechanoregulation of Amnion Patterning through Activation of Bone Morphogenetic Protein Signaling
合作研究:通过激活骨形态发生蛋白信号传导对羊膜模式进行机械调节
- 批准号:
2325361 - 财政年份:2023
- 资助金额:
$ 13.78万 - 项目类别:
Standard Grant
Collaborative Research: Mechanoregulation of Amnion Patterning through Activation of Bone Morphogenetic Protein Signaling
合作研究:通过激活骨形态发生蛋白信号传导对羊膜模式进行机械调节
- 批准号:
2325360 - 财政年份:2023
- 资助金额:
$ 13.78万 - 项目类别:
Standard Grant
Evaluation of in vivo kinetics and fate of amnion epithelial stem cells after intraportal transplantation using transgenic pigs
转基因猪门静脉内移植后羊膜上皮干细胞的体内动力学和命运评估
- 批准号:
22H03139 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Amnion membrane organ-on-chip for modeling intra-amniotic infection
用于模拟羊膜内感染的羊膜器官芯片
- 批准号:
10372321 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Development of new carriers utilizing with transplantation rejection mechanism in amnion membrane derived cells
利用羊膜来源细胞移植排斥机制开发新载体
- 批准号:
22K19557 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Amnion membrane organ-on-chip for modeling intra-amniotic infection
用于模拟羊膜内感染的羊膜器官芯片
- 批准号:
10650713 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Amnion cell therapy for acute and chronic stroke
羊膜细胞疗法治疗急性和慢性中风
- 批准号:
nhmrc : 2003156 - 财政年份:2021
- 资助金额:
$ 13.78万 - 项目类别:
Ideas Grants
Examination of the therapeutic effect on inflammatory bowel disease using HSPB6-positive exosomes derived from amnion-derived MSCs
使用源自羊膜间充质干细胞的 HSPB6 阳性外泌体检查对炎症性肠病的治疗效果
- 批准号:
21K07952 - 财政年份:2021
- 资助金额:
$ 13.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the mechanism of placental amnion-chorion membranes on periodontal regeneration
胎盘羊膜绒毛膜促进牙周再生的机制研究
- 批准号:
21K16974 - 财政年份:2021
- 资助金额:
$ 13.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists